Latest Medical Physics research
The 10 most useful medical physics studies published this week, chosen from Q1 journals and graded on the Oxford CEBM evidence hierarchy. Each paper links to a short summary and the original on PubMed. Updated 7 November 2026.
Top 10 this week
Week of 1 November 2026
- 1
Efficacy and safety of curative-intent intensity modulated radiotherapy (IMRT) for inoperable, locally-advanced non-small cell lung cancer: A systematic review
Journal of cancer research and therapeutics · Q2 journal · SR/MA of RCTs · Evidence level 1 (High) · 29 October 2026
This review included 936 patients in randomized trials and 1,093 in non-randomized studies; none directly compared intensity-modulated radiotherapy with 3D-CRT for locally advanced lung cancer. Standard-dose treatment appeared safe and was associated with less severe pneumonitis and lower heart doses, but varied evidence limits certainty, and intensifying treatment warrants caution in patients with large targets, major blood-vessel involvement, or significant coughing of blood.
- 2
Model-Based Normal Tissue Complication Probability Comparison Between Proton and Photon Therapies for Brain Tumors Complying With Planning Study Guidelines
Advances in radiation oncology · Q1 journal · RCT · Evidence level 1 (High) · 19 October 2026
In planning comparisons for 66 patients, proton therapy had lower estimated risks of cataracts, memory problems, hearing impairment, tinnitus, and secondary brain cancer than intensity-modulated radiation therapy; 31 patients had at least one difference exceeding the study's threshold for clinical importance. Proton plans also showed higher estimated risks of hair loss, blindness, and brain necrosis, and whether these modeled differences translate into patient outcomes remains unknown.
- 3
Prospective evaluation of an optimized low-dose CT enterography protocol for patients with Crohn's disease
European journal of radiology · Q1 journal · RCT · Evidence level 5 (Expert Opinion) · 23 October 2026
Randomized evaluation of CT dose reduction and image quality
- 4
Is full re-optimization necessary in adaptive radiotherapy for head and neck cancer? A systematic review of dosimetric and clinical outcomes
Journal of cancer research and therapeutics · Q2 journal · SR of cohorts · Evidence level 2 (Moderate) · 29 October 2026
Across nine studies of head and neck cancer, adaptive radiotherapy consistently improved tumor target coverage and sparing of nearby organs. Effects on local control, survival, toxicity, and quality of life were inconsistent, and the studies used varied methods. The review found no direct evidence that every patient needs full re-optimization, leaving the best approach and timing uncertain.
- 5
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO Clinical Practice Guideline
Practical radiation oncology · Q1 journal · Guideline · Evidence level 1 (High) · 27 October 2026
The guideline recommends moderate hypofractionation over conventional radiation for all risk groups, with randomized evidence showing comparable cancer control, toxicity and quality of life in less treatment time. Very short schedules are a standard option for low- and intermediate-risk disease, but their role in high-risk cancer remains less certain; patients with significant urinary problems may be better suited to moderate schedules.
- 6
Ultrafast brain MRI at 3 T for suspected acute ischemic stroke: interchangeability of the ultrafast and standard protocols
Japanese journal of radiology · Q2 journal · Cohort · Evidence level 3 (Low) · 31 October 2026
In 100 patients with suspected acute stroke, the ultrafast 3 T MRI protocol took 1 minute 43 seconds instead of 4 minutes 29 seconds, while matching the standard protocol for detecting lesions, affected vascular territories and relevant secondary findings. Image quality scores were slightly higher, but the work-in-progress diffusion imaging algorithm still needs further validation.
- 7
Clinical outcomes and dosimetric factors associated with local control after two-fraction radiosurgery for brain metastases
Radiation oncology journal · Q2 journal · Cohort · Evidence level 3 (Low) · 30 October 2026
In this retrospective study of 193 brain metastases, local failure reached 17.9% at 12 months after two-fraction radiosurgery. Lower dose coverage of nearly the entire target was independently associated with more local failures, while distant brain failure reached 50.2% by one year. The findings link target dosing to local control, but do not establish a specific dose threshold.
- 8
AAPM Medical Physics Practice Guideline 18.a: Superficial radiation therapy using low-energy kilovoltage x-rays
Journal of applied clinical medical physics · Q2 journal · Guideline · Evidence level 1 (High) · 1 November 2026
The medical physics guideline outlines commissioning and daily, monthly, and annual quality checks for superficial radiation therapy using low-energy x-rays. It also covers treatment planning and delivery, regulatory requirements, shielding, and staff monitoring to support consistent, safe practice. The report sets minimum standards, but does not assess whether treatment improves patient outcomes.
- 9
CERVICAL CANCER: NATIONAL CLINICAL PRACTICE GUIDELINES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
Journal of gynecology obstetrics and human reproduction · Q2 journal · Guideline · Evidence level 1 (High) · 27 October 2026
A multidisciplinary panel produced 158 recommendations across cervical cancer care, based on evidence review and validation by 87 independent reviewers; 71 clinical questions had insufficient evidence for a recommendation. Key updates include avoiding minimally invasive hysterectomy from stage IB1 and using image-guided brachytherapy after chemoradiotherapy, but care choices still depend on the evidence gaps.
- 10
Nursing radiation-protection compliance and 30-day wound and pin-site adverse events after supracondylar humerus fracture fixation in children
Frontiers in pediatrics · Q2 journal · Retrospective cohort · Evidence level 3 (Low) · 15 October 2026
Among 256 children having fracture fixation, 21% in the low-compliance group had a wound or pin-site event within 30 days, compared with 11% in the high-compliance group. After adjustment, the association weakened and was statistically imprecise, so compliance is an exploratory marker of perioperative quality, not an established predictor or cause.
Paper of the day, last two weeks
Development of an Electronic Clinical Quality Measure for Excessive Radiation Dose or Inadequate Image Quality in Diagnostic CT in Adults
Journal of the American College of Radiology : JACR · Q1 journal · Review / opinion · Evidence level 5 (Expert Opinion) · 3 November 2026
Validated automated measure for CT dose and image quality
OpenTOPAS-SPECT: an extension for full-physics clinical and preclinical SPECT simulation
Physics in medicine and biology · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 3 November 2026
The new SPECT simulation tool matched full-transport precision 6.9 times faster in a tested point-source setup, while reproducing absolute sensitivity to within 1%. Across 20 configurations, its faster forced-detection method stayed within 4% of full transport when septa carried up to a fifth of the signal, but undercounted more when septal contribution was higher. Reconstructed-image accuracy remains untested.
Early Implementation Performance of the CMS Electronic Clinical Quality Measure for Excessive Radiation Dose or Inadequate Image Quality in Diagnostic CT: An Evaluation of 254 Facilities
Journal of the American College of Radiology : JACR · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 3 November 2026
Large-scale evaluation of CT dose and image-quality monitoring
High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial
International journal of radiation oncology, biology, physics · Q1 journal · Non-randomized trial · Evidence level 2 (Moderate) · 2 November 2026
In this prospective trial of 60 patients receiving high-dose reirradiation for recurrent lung cancer, 10 developed grade 3 toxicity, including 7 with radiation pneumonitis; no grade 4 or 5 toxicity occurred over a median 26 months. Higher cumulative lung dose measures were linked to moderate or severe pneumonitis, so careful dose planning remains key.
Angle-Dependent Dose Transformer Algorithm for Fast Proton Therapy Dose Calculations
International journal of particle therapy · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 8 October 2026
Proton dose calculation model validated against independent patient cohort
Angle-Dependent Dose Transformer Algorithm for Fast Proton Therapy Dose Calculations
International journal of particle therapy · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 8 October 2026
Proton dose calculation model validated against independent patient cohort
Angle-Dependent Dose Transformer Algorithm for Fast Proton Therapy Dose Calculations
International journal of particle therapy · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 8 October 2026
Proton dose calculation model validated against independent patient cohort
Three-dimensional computational evaluation of water-to-air mass stopping power ratio for therapeutic helium-, carbon-, oxygen-, and neon-ion beams and its application to patient-specific quality assurance
Physics in medicine and biology · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 30 October 2026
In treatment-plan simulations, the average water-to-air stopping power ratio within targets was 1.128 for carbon and oxygen ions and 1.129 for helium and neon ions, rather than the standard 1.126. Ratios varied across the target, with shallow neon plans sometimes exceeding the standard uncertainty range in a small distal region; patient-specific calculations could refine quality assurance, but clinical impact remains untested.
Practical considerations of gadoxetate disodium contrast in MRI-guided liver SBRT for primary and secondary liver tumors: optimizing image quality and patient throughput
Practical radiation oncology · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 26 October 2026
Among 23 patients receiving MRI-guided liver radiation, images taken 20 to 30 minutes after contrast showed better tumor visibility and border definition than pre-contrast or earlier images. In the six patients assessed for contouring, median tumor volume left untreated fell from 3.68 to 0.68 cm3. The small contouring sample limits certainty, but the findings suggest timing contrast could reduce geographic miss.
Six-year data from three magnetic resonance-guided radiotherapy systems demonstrate long-term stability of linear accelerator quality assurance
Physics and imaging in radiation oncology · Q1 journal · Cohort · Evidence level 3 (Low) · 23 September 2026
Over six years at one institution, three MRI-guided radiotherapy systems stayed within tolerance limits on 11 of 13 quality checks. The other two checks slightly exceeded limits, but the deviations were understood and not considered clinically relevant; no clinically important worsening trends emerged. The findings support reviewing QA programs, but do not establish which checks can safely be reduced.
Practical considerations of gadoxetate disodium contrast in MRI-guided liver SBRT for primary and secondary liver tumors: optimizing image quality and patient throughput
Practical radiation oncology · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 26 October 2026
Among 23 patients receiving MRI-guided liver radiation, images taken 20 to 30 minutes after contrast showed better tumor visibility and border definition than pre-contrast or earlier images. In the six patients assessed for contouring, median tumor volume left untreated fell from 3.68 to 0.68 cm3. The small contouring sample limits certainty, but the findings suggest timing contrast could reduce geographic miss.
ESTRO-EPTN guidelines for independent dose calculation and log file-based patient-specific quality assurance in scanned particle therapy
Physics and imaging in radiation oncology · Q1 journal · Guideline · Evidence level 1 (High) · 10 October 2026
New European consensus guidelines recommend independent dose calculation to verify the treatment plan and log file review to assess what was delivered in scanned particle therapy. When validated and combined with robust machine quality checks, the methods can detect clinically relevant deviations and reduce reliance on phantom measurements. Their safe use still depends on managing model limits, risks, and data traceability.
Evaluation of quantitative accuracy in 4D DCE-bCT: Insights from a perfusion phantom study
Medical physics · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 1 November 2026
Perfusion phantom measures quantitative dynamic CT accuracy
Evaluation of quantitative accuracy in 4D DCE-bCT: Insights from a perfusion phantom study
Medical physics · Q1 journal · Unclassified · Evidence level 5 (Expert Opinion) · 1 November 2026
Perfusion phantom measures quantitative dynamic CT accuracy
Get this list every morning
The Web of Medicine app builds this feed for your specialty daily, with filters by evidence level and journal, audio summaries and Ask AI. Free on iOS and Android.
For healthcare professionals. Summaries are generated by AI from the published abstract and are not medical advice. Read the original paper before changing practice.